Cocrystal Pharma Inc (COCP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.07
• Market Cap: $14.26M
• EPS: $-0.93
• 52-Week High: $2.19
• 52-Week Low: $0.86

Market Sentiment

Cocrystal Pharma Inc currently has a Bullish sentiment score of 0.36.

About Cocrystal Pharma Inc

Cocrystal Pharma, Inc. (COCP) is a forward-thinking biotechnology company specializing in the development of antiviral therapies for serious and chronic viral infections. Positioned in Bothell, Washington, the company utilizes cutting-edge technologies to innovate and advance its proprietary drug candidates, aiming to meet significant unmet medical needs within the antiviral realm. With a solid research foundation, Cocrystal Pharma is committed to transforming treatment paradigms and enhancin...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cocrystal Pharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does COCP pay dividends?

Cocrystal Pharma Inc (COCP) does not currently pay a regular dividend.

What is COCP's market cap?

Cocrystal Pharma Inc (COCP) has a market capitalization of $14.26M with a current stock price of $1.07.